⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18573249 | 1.00 | — | — | |
| SCHEMBL18573247 | 1.00 | — | — | |
| SCHEMBL18576609 | 1.00 | — | — | |
| SCHEMBL18576429 | 1.00 | — | — | |
| SCHEMBL14155041 | 1.00 | — | — | |
| SCHEMBL23182853 | 1.00 | — | — | |
| SCHEMBL15945068 | 1.00 | — | — | |
| SCHEMBL8051255 | 0.94 | — | — | |
| SCHEMBL24059361 | 0.89 | — | — | |
| SCHEMBL20387145 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023239727-A1 | LATS INHIBITORS AND USES THEREOF | THE USA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) | 2023-12-14 | — | — | WO | disclosed |
| WO-2023149761-A1 | ORGANIC MOLECULES USABLE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-08-10 | — | — | WO | disclosed |
| WO-2023106310-A1 | AROMATIC HETEROCYCLIC DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST ACTIVITY | 塩野義製薬株式会社 | 2023-06-15 | — | — | WO | disclosed |
| WO-2023077046-A1 | INHIBITORS OF HIF-2ALPHA AND METHODS OF USE THEREOF | ARCUS BIOSCIENCES, INC. (US) | 2023-05-04 | — | — | WO | disclosed |
| EP-3430017-B1 | COMPOSITIONS AND METHODS FOR TREATING PARASITIC DISEASES | UNIV CALIFORNIA (US) | 2023-01-25 | — | — | EP | disclosed |
| EP-4023636-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, PATTERN FORMATION METHOD, RESIST FILM, AND ELECTRONIC DEVICE PRODUCTION METHOD | FUJIFILM Corporation (JP) | 2022-07-06 | — | — | EP | disclosed |
| WO-2022036292-A1 | TEXAPHYRIN DERIVATIVES FOR MANGANESE CHEMOTHERAPY, PHOTOACOUSTIC IMAGING, AND PHOTOTHERMAL THERAPY | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2022-02-17 | — | — | WO | disclosed |
| US-20200216401-A1 | NOVEL SYRINGOLIN ANALOGUES AND METHODS OF MAKING AND USING SAME | UNIV BROWN (US) | 2020-07-09 | — | — | US | disclosed |
| WO-2019018583-A1 | 1,8-NAPHTHYRIDINONE COMPOUNDS AND USES THEREOF | GiraFpharma LLC (US) | 2019-01-24 | — | — | WO | disclosed |
| WO-2017161344-A1 | COMPOSITIONS AND METHODS FOR TREATING PARASITIC DISEASES | THE REGANTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-09-21 | — | — | WO | disclosed |
| EP-1403356-B1 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2008-09-17 | — | — | EP | disclosed |
| EP-1947515-A2 | Electrophotographic photosensitive member, and electrophotgraphic apparatus and process cartridge which make use of the same | Canon Kabushiki Kaisha (JP) | 2008-07-23 | — | — | EP | disclosed |
| EP-1495018-B1 | TRICYCLIC THROMBIN RECEPTOR ANTAGONISTS | SCHERING CORP (US) | 2007-11-14 | — | — | EP | disclosed |
| US-20070135508-A1 | 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists | RANBAXY LABORATORIES LIMITED (IN) | 2007-06-14 | — | — | US | disclosed |
| US-20070135508-A1 | 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists | RANBAXY LABORATORIES LIMITED (IN) | 2007-06-14 | — | — | US | disclosed |
| US-7230116-B2 | Pyrazolyl-substituted heterocycles and their use as phytosanitary products | BAYER CROPSCIENCE, AG (DE) | 2007-06-12 | — | — | US | disclosed |
| EP-1656379-B1 | 4-CYCLOALKYLAMINOPYRAZOLO PYRIMIDINE NMDA/NR2B ANTAGONISTS | MERCK & CO INC (US) | 2007-01-10 | — | — | EP | disclosed |
| US-6040449-A | USEFUL FOR FORMING FLUORINE CONTAINING 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES, USEFUL AS ANTAGONIST FOR MUSCARINIC M3 RECEPTORS AND LESS SIDE EFFECT | BANYU PHARMACEUTICAL CO LTD (JP) | 2000-03-21 | — | — | US | disclosed |
| US-5948792-A | POTENT AND SELECTIVE ANTAGONISTS FOR MUSCARINIC M.SUB.3 RECEPTORS WITH LITTLE SIDE EFFECTS. | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1999-09-07 | — | — | US | disclosed |
| EP-0930298-A1 | FLUORINATED 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1999-07-21 | — | — | EP | disclosed |